Baxter BioPharma Solutions has completed the acquisition of Claris Injectables, a global generic injectables pharmaceutical company. The transaction broadens Baxter’s presence in the generic pharmaceuticals space and will help boost the supply of essential medicines to Baxter customers. “This acquisition reinforces our commitment to establishing Baxter as a global leader in generic injectable medicines,” said José Almeida, chairman and chief executive officer, Baxter. “The combination of Baxt...